ITGR Integer Holdings Corporation
XNYS 126.56 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ITGR
$126.56
—
What changed
Recent filings, trades and movesKey stats
$126.56
- 52-Week Range
- $66.51 – $126.83
- YTD
- +64.83%
- IV Rank (30D)
- 9.17
- Straddle Price
- $1.20
- P/C Vol Ratio
- 0.10
- Market Cap
- $4.3B
- Open
- $126.70
- Day Range
- $126.55 – $126.71
- Volume
- 714,857
- Prev Close
- $126.56
Fair Value
MODEL: SHORT
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 0.85 |
| Cost of Equity (CAPM) | 9.17% (VRP-adj) |
| WACC | 8.57% |
| Volatility Risk Premium | +46.8pp (IV − HV30) |
| Effective Tax Rate | 3.9% |
| Rev. Growth (YoY, DCF input) | -4.7% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $0.1B |
| Return on Equity (TTM) | 6.0% |
| Book / Price | 39.4% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 24.6% |
| FCF Margin (TTM) | 4.5% |
| Debt / Equity | 0.73 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $126.34 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $126.62 |
| Bollinger Width / SMA20 | 0.3% (drives anchor stability) |
| Net Debt | $1.3B |
| Market Cap | $4B |
Peers used for multiples: ABT, MDT, OGN, PCRX, TFX
(filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
66%
20-Day Fair Value
≈ by Dec 8, 2026
$125.06
α -1.2%
rank 49%
conviction
72%
40-Day Fair Value
≈ by Jan 6, 2027
$123.16
α -2.7%
rank 49%
conviction
75%
60-Day Fair Value
≈ by Feb 4, 2027
$123.01
α -2.8%
rank 49%
conviction
66%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $-7.37 | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $98.20 | 9% | median 33.7× · 4 peers |
| Peer EV/EBITDA | $106.59 | 9% | median 16.0× · 5 peers |
| Peer P/B | $133.21 | 9% | median 2.7× · 5 peers |
| Peer P/S | $167.22 | 9% | median 3.2× · 5 peers |
| Market Anchor (SMA50) | $126.34 | 62% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $131.36 | 0% | 5 strikes · skew +1.32 |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS (3845) · industry map
- Exchange
- XNYS
- Market Cap
- $4.3B
- Employees
- 11,000
- List Date
- 2000-09-28
- CIK
- 0001114483
- Last Earnings
- Oct 29 before open · −0.0% vs ±1.9% expected
- Next Earnings
- ~Feb 18, 2027 (estimated)
- Headquarters
- Plano, TX
- Homepage
- https://www.integer.net
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -6.30% | -7.70% | -3.88% | 3.14% | 7.60% | 13.13% | 1.00% |
| Feb | 19.11% | 5.98% | 8.75% | 6.22% | -10.88% | 1.32% | 5.08% |
| Mar | -0.35% | -0.26% | 1.27% | 4.63% | -1.83% | 1.92% | 0.90% |
| Apr | 3.30% | -8.92% | 9.16% | -3.76% | 6.54% | 2.39% | 1.45% |
| May | -4.39% | 4.88% | -1.10% | 10.44% | -5.44% | 6.37% | 1.79% |
| Jun | 3.74% | -9.42% | 7.24% | -4.56% | 4.49% | 3.65% | 0.86% |
| Jul | 2.91% | -2.93% | 4.52% | 3.13% | -10.54% | 27.51% | 4.10% |
| Aug | 2.45% | -10.00% | -7.90% | 11.97% | 1.27% | 0.64% | -0.26% |
| Sep | -9.84% | -0.11% | -7.74% | 2.47% | -3.40% | 0.77% | -2.98% |
| Oct | -2.28% | -2.07% | 4.01% | -2.31% | -37.26% | 0.13% | -6.63% |
| Nov | -10.00% | 16.34% | 5.82% | 11.11% | 7.84% | 0.01%* | 5.19% |
| Dec | 7.31% | -7.60% | 11.77% | -4.50% | 9.31% | -- | 3.26% |
| Total | 2.23% | -22.45% | 33.90% | 42.62% | -35.86% | 70.78% | 15.20% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $126.62
SMA 50: $126.37
SMA 200: $102.04
Current: $126.56
EMA 12: $126.60
EMA 26: $126.41
MACD: 0.1902 | Signal: -0.0855
BULLISH
ADX (14): 52.54
STRONG TREND
+DI: 19.26
−DI: 9.56
Momentum Oscillators
RSI (14): 57.49
NEUTRAL
Stoch %K: 38.31
Stoch %D: 43.28
Williams %R: -80.60
Volume & Volatility
BB Upper: $126.78
BB Lower: $126.46
NEUTRAL
OBV: 1,737,104
Vol SMA 20: 822,325
Vol ROC: -13.65%
ATR: $0.21
True Range: $0.16
HV 20: 1.3%
HV 30: 1.1%
HV 60: 2.3%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-11T00:00:00 – 2026-11-09T00:00:00
AI Analysis
Written before ITGR’s Oct 29 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report
Executive Summary BULLISH (Confidence Level: 7/10) Key drivers: Recent positive news headlines, bullish technical signals Primary risks: Earnings miss, regulatory issues
Investment thesis: Integer's recent performance is driven by a combination of positive news sentiment and technical momentum. The stock has formed a solid uptrend, supported by strong indicators like MACD and RSI. While there are some risks to consider, the overall outlook remains bullish.
Recent news sentiment impact: Recent headlines have been generally positive, with a focus on Integer's upcoming conference appearance and its participation in industry trends.
Technical Analysis Trend Direction:
- Short-term (1-4 weeks): Uptrend
- Medium-term (1-3 months): Bullish momentum
- Long-term (3-12 months): Neutral
Support/Resistance Levels:
- SMA 20: $92.03 (strong support)
- SMA 50: $90.19 (support)
- Upper Bollinger Band: $95.27 (resistance)
Momentum Signals:
- RSI: 55.68 (neutral)
- MACD: Bullish momentum
- Stochastic %K/D: Neutral
Volume Analysis:
- Volume SMA 20: 462858.65 (increasing)
- OBV: -14667597.22 (negative)
- Volume Rate of Change: -24.09% (decreasing)
News & Sentiment Analysis Recent Headlines Summary: The past 10 news articles have been generally positive, focusing on Integer's upcoming conference appearance and its participation in industry trends.
Sentiment Assessment: Aggregate sentiment is POSITIVE (60%).
Catalyst Identification: Upcoming conference appearance, potential earnings beats
Market Narrative: Recent news headlines align with the overall bullish technical signals, suggesting a strong market narrative.
Risk & Volatility Assessment Beta Interpretation: Low risk relative to market (beta = 0.62)
Volatility Regime: Current volatility is lower than historical levels (HV20 = 24.8%, HV30 = 24.3%)
Options Market Signals:
- IV Rank: 22.2% (Low)
- Put/Call Volume Ratio: 0.53 (Bullish sentiment)
- Put/Call OI Ratio: 1.83
Downside Protection:
- SMA 20 support at $92.03
- Lower Bollinger Band support at $88.79
Market Context & Positioning Sector Performance: Medical devices sector has been relatively strong.
Institutional Activity: Volume patterns suggest institutional interest is increasing.
Correlation Analysis: Integer's price movement is relatively low correlated with the broader market (R-squared = 0.18).
Relative Valuation: The stock is trading within a range, suggesting fair value.
Key Levels & Action Items Critical Price Levels:
- SMA 20 support at $92.03
- Upper Bollinger Band resistance at $95.27
Breakout/Breakdown Levels:
- SMA 50 support at $90.19 (breakout level)
- Lower Bollinger Band support at $88.79 (breakdown level)
Time-Sensitive Catalysts: Upcoming conference appearance, potential earnings beats
Risk Management: Consider stop-loss levels at SMA 20 and upper Bollinger Band resistance. Position sizing considerations should prioritize risk management.
Note that the data quality flags are not activated in this analysis as all necessary data is present.
Generated
News
All ITGR news →
Earnings History
17 of 20 under expected move
Avg Expected Move
6.83%
Avg Actual Move
3.30%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-04-29 | Pre-Market | 5.84% | 0.77% | 0.13x | Within |
| 2021-07-29 | Pre-Market | 6.12% | 0.86% | 0.14x | Within |
| 2021-10-28 | Pre-Market | 5.68% | 1.03% | 0.18x | Within |
| 2022-02-17 | Pre-Market | 2.22% | 0.27% | 0.12x | Within |
| 2022-04-28 | Pre-Market | 9.02% | 0.04% | 0.00x | Within |
| 2022-10-05 | Pre-Market | 4.56% | 0.68% | 0.15x | Within |
| 2023-04-27 | Pre-Market | 1.45% | 5.72% | 3.94x | Exceeded |
| 2023-07-27 | Pre-Market | 7.30% | 7.18% | 0.98x | Within |
| 2023-10-26 | Pre-Market | 8.17% | 15.59% | 1.91x | Exceeded |
| 2024-01-10 | Pre-Market | 4.60% | 0.76% | 0.17x | Within |
| 2024-04-25 | Pre-Market | 7.30% | 9.83% | 1.35x | Exceeded |
| 2024-07-25 | Pre-Market | 8.09% | 7.12% | 0.88x | Within |
| 2024-10-24 | Pre-Market | 8.34% | 0.18% | 0.02x | Within |
| 2025-04-24 | Pre-Market | 8.84% | 0.79% | 0.09x | Within |
| 2025-07-24 | After-Close | 6.44% | 1.32% | 0.20x | Within |
| 2025-10-23 | After-Close | 10.08% | 1.33% | 0.13x | Within |
| 2026-02-19 | Pre-Market | 13.24% | 4.02% | 0.30x | Within |
| 2026-04-30 | Pre-Market | 13.45% | 5.78% | 0.43x | Within |
| 2026-08-03 | Pre-Market | 3.96% | 2.67% | 0.67x | Within |
| 2026-10-29 | Pre-Market | 1.94% | 0.02% | 0.01x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
ITGR Options Activity & IV Rank
ITGR IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 10.6%
7-DTE IV: 19.1%
Expected Move: $1.20
7-DTE Move: $6.67
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 2,379
Put Volume: 238
P/C Volume: 0.1
BULLISH
Call OI: 20,991
Put OI: 955
P/C OI: 0.045
Total OI: 21,946
ATM Options Pricing
ATM Call: $1.05
ATM Put: $0.15
Call %: 0.8%
Put %: 0.1%
Chain Summary
Chain Volume: 2,617
Chain OI: 21,946
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 96th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
96%
vs own history
GEX tilt
+0.95
OI-weighted, today
Vanna tilt
+1.00
δ-sensitivity to IV
Charm tilt
-1.00
δ-decay vs time
Vanna tilt +1.00: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -1.00: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 9 ATM contracts, 11k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)17.4LowNov 9
IV Rank (30 DTE)9.2LowNov 9
Straddle Price (30 DTE)$1.20Nov 9
Beta Analysis
Risk Metrics
Beta: 0.5856
Alpha: 59.41%
Correlation: 0.2566
R-Squared: 6.6%
Stock Volatility: 31.4%
Market Volatility: 13.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ITGR
3 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $90.2M | #444 of 6285 | +39.3% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $34.1M | #817 of 3716 | -21.6% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $446K | #2143 of 4729 | -1.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ITGR Institutional Ownership (13F)
Filings for 2026-06-30 · 141 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 35,080,250 (as of 2026-10-02)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
4 filers$74.24M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | UBS Group AG Custodian | $61.91M | 83.38% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $9.53M | 12.84% | 2026-06-30 |
| 3 | Centiva Capital, LP | $2.80M | 3.78% | 2026-06-30 |
| 4 | FNY Investment Advisers, LLC | $0 | 0.00% | 2026-09-30 |
3 filers$4.96M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $3.49M | 70.24% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $1.24M | 25.05% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $233.62K | 4.71% | 2026-06-30 |
ITGR Insider Trading (Form 4)
Latest: 2026-10-26Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-26 | Payman Khales | President & CEO | Mixed Exer +2,514 · Tax −990 |
+1,524 | $126.54 | -$125.3K | EDGAR |
| 2026-09-16 | Kirk K Thor | Chief Human Resources Officer | Sell (S) | −31,540 | $126.24 | -$3.98M | EDGAR |
| 2026-09-10 | Andrew Senn | President, Growth & Innovation | Sell (S) | −9,408 | $126.30 | -$1.19M | EDGAR |
| 2026-07-10 | Milo Stephen Metcalf II | US - EVP, Operations | Grant (A) | +5,424 RSU | — | EDGAR | |
| 2026-07-01 | Kirk K Thor | Chief Human Resources Officer | Mixed Tax −2,409 · Exer +6,120 |
+3,711 | $93.45 | -$225.1K | EDGAR |
| 2026-07-01 | John A Harris | President, Glob Ops & Manu Tec | Grant (A) | +1,096 RSU | — | EDGAR | |
| 2026-05-22 | Filippo Passerini | Director | Award (A) | +1,967 | — | EDGAR | |
| 2026-05-22 | Donald J Spence | Director | Grant (A) | +2,623 RSU | — | EDGAR | |
| 2026-05-22 | James F. Hinrichs | Director | Grant (A) | +1,967 RSU | — | EDGAR | |
| 2026-05-22 | Tommy P Thomas | VP, Corporate Controller | Grant (A) | +666 RSU | — | EDGAR | |
| 2026-05-22 | Aaron Kapito | Director | Award (A) | +1,967 | — | EDGAR | |
| 2026-05-22 | Sheila Antrum | Director | Award (A) | +1,967 | — | EDGAR | |
| 2026-05-22 | James Francis Flanagan | Director | Award (A) | +1,967 | — | EDGAR | |
| 2026-05-22 | Cheryl C Capps | Director | Award (A) | +1,967 | — | EDGAR | |
| 2026-05-22 | Alvin Tyrone Jeffers | Director | Award (A) | +1,967 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ITGR Insider Holdings
24 insiders · @ $126.56
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Payman Khales | President & CEO | 63,378 | $8.02M | -$788.7K | 25 | 2026-10-26 |
| 2 | Joseph W Dziedzic | President & CEO | 59,202 | $7.49M | -$41.15M | 32 | 2025-06-13 |
| 3 | Pamela G Bailey | Director | 56,052 | $7.09M | -$2.89M | 22 | 2026-01-05 |
| 4 | Filippo Passerini | Director | 31,114 | $3.94M | $0 | 14 | 2026-05-22 |
| 5 | Martin C Maxwell | Director | 25,106 | $3.18M | -$1.51M | 17 | 2026-05-22 |
| 6 | Donald J Spence | Director | 18,781 | $2.38M | -$6.63M | 17 | 2026-05-22 |
| 7 | Cheryl C Capps | Director | 13,669 | $1.73M | $106.7K | 8 | 2026-05-22 |
| 8 | Diron Smith | EVP, Chief Financial Officer | 13,421 | $1.70M | $75.0K | 12 | 2026-05-12 |
| 9 | Sheila Antrum | Director | 12,069 | $1.53M | $0 | 7 | 2026-05-22 |
| 10 | Margaret Carthy | EVP, Qlty & Regulatory Affairs | 10,033 | $1.27M | $0 | 7 | 2025-02-25 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ITGR Board & Officers
As of SEC filings through Oct 26, 2026Directors 13
- Pamela G Bailey · on file since 2006
- Filippo Passerini · since Jul 2, 2015
- Jean M. Hobby · since Jul 2, 2015
- Martin C Maxwell · since Jul 2, 2015
- Donald J Spence · since Oct 17, 2016
- James F. Hinrichs · since Feb 12, 2018
- Alvin Tyrone Jeffers · since Feb 1, 2021
- Cheryl C Capps · since Feb 1, 2021
- Sheila Antrum · since Feb 1, 2021
- Michael J Coyle · since Jul 10, 2025
- Payman Khales · listed since Oct 2025
- Aaron Kapito · since Mar 12, 2026
- James Francis Flanagan · since Mar 12, 2026
Officers 9
- Payman Khales · President & CEO · listed since Oct 2025
- Diron Smith · EVP, Chief Financial Officer · listed since Jan 2024
- Kirk K Thor · Chief Human Resources Officer · since Jan 2, 2018
- Lindsay K. Blackwood · SVP, Gen Counsel & Secretary · since Mar 24, 2025
- John A Harris · EVP, Global Ops and Manufactur · listed since Jan 2024
- Terence Carr · EVP, Qlty & Regulatory Affairs · since May 5, 2025
- Milo Stephen Metcalf II · US - EVP, Operations · since Jul 6, 2026
- Tommy P Thomas · VP, Corporate Controller · since Feb 5, 2018
- Andrew Senn · SVP, Strategy and Business Dev · since Mar 11, 2022
10% owners 14
- George R Roberts · since Oct 5, 2026
- Henry R Kravis · since Oct 5, 2026
- KKR & Co. Inc. (entity) · since Oct 5, 2026
- KKR Associates Group GP LLC (entity) · since Oct 5, 2026
- KKR Associates Group L.P. (entity) · since Oct 5, 2026
- KKR Associates North America XIV SCSp (entity) · since Oct 5, 2026
- KKR Group Co. Inc. (entity) · since Oct 5, 2026
- KKR Group Holdings Corp. (entity) · since Oct 5, 2026
- KKR Group Partnership L.P. (entity) · since Oct 5, 2026
- KKR Management LLP (entity) · since Oct 5, 2026
- KKR North America Fund XIV SCSp (entity) · since Oct 5, 2026
- KKR North America XIV S.a r.l. (entity) · since Oct 5, 2026
- Tarheel Investors III GP LLC (entity) · since Oct 5, 2026
- Tarheel Investors III L.P. (entity) · since Oct 5, 2026
Changes in the last 10 years (67)
| Oct 5, 2026 | Tarheel Investors III L.P. became a 10% owner |
| Oct 5, 2026 | Tarheel Investors III GP LLC became a 10% owner |
| Oct 5, 2026 | KKR North America XIV S.a r.l. became a 10% owner |
| Oct 5, 2026 | KKR North America Fund XIV SCSp became a 10% owner |
| Oct 5, 2026 | KKR Management LLP became a 10% owner |
| Oct 5, 2026 | KKR Group Partnership L.P. became a 10% owner |
| Oct 5, 2026 | KKR Group Holdings Corp. became a 10% owner |
| Oct 5, 2026 | KKR Group Co. Inc. became a 10% owner |
| Oct 5, 2026 | KKR Associates North America XIV SCSp became a 10% owner |
| Oct 5, 2026 | KKR Associates Group L.P. became a 10% owner |
| Oct 5, 2026 | KKR Associates Group GP LLC became a 10% owner |
| Oct 5, 2026 | KKR & Co. Inc. became a 10% owner |
| Oct 5, 2026 | Henry R Kravis became a 10% owner |
| Oct 5, 2026 | George R Roberts became a 10% owner |
| Jul 6, 2026 | Milo Stephen Metcalf II became US - EVP, Operations |
| Jun 24, 2026 | The company announced the departure of Jim Stephens as President, CRM & Neuro in an SEC filing |
| Mar 12, 2026 | James Francis Flanagan became a director |
| Mar 12, 2026 | Aaron Kapito became a director |
| Oct 27, 2025 | Payman Khales listed as President & CEO (previously President, C&V) in SEC filings |
| Oct 27, 2025 | Payman Khales first listed as a director in an SEC filing |
| Jul 10, 2025 | Michael J Coyle became a director |
| May 5, 2025 | Terence Carr became EVP, Qlty & Regulatory Affairs |
| Apr 21, 2025 | The company announced the departure of Joseph W Dziedzic from the board in an SEC filing |
| Apr 21, 2025 | The company announced the departure of Joseph W Dziedzic as President & CEO in an SEC filing |
| Apr 7, 2025 | Sanjiv Arora became SVP, Investor Relations |
| Mar 24, 2025 | Lindsay K. Blackwood became SVP, Gen Counsel & Secretary |
| Feb 27, 2025 | The company announced the departure of William B Summers Jr from the board in an SEC filing |
| Jul 8, 2024 | The company announced the departure of McAlister C Marshall II as SVP, Gen Counsel & Secretary in an SEC filing |
| Jan 23, 2024 | Margaret Carthy listed as EVP, Qlty & Regulatory Affairs (previously SVP, Quality & Regulatory Affa) in SEC filings |
| Jan 23, 2024 | John A Harris listed as EVP, Global Ops and Manufactur (previously Interim President, C&V) in SEC filings |
| Jan 23, 2024 | Diron Smith listed as EVP, Chief Financial Officer (previously VP, Interim CFO) in SEC filings |
| Sep 11, 2023 | The company announced the departure of Jennifer M Bolt as EVP, Global Operations & ESG in an SEC filing |
| May 24, 2023 | Jim Stephens became President, CRM & Neuro |
| May 8, 2023 | Diron Smith became VP, Interim CFO |
| May 6, 2023 | The company announced the departure of Jason K Garland as EVP, Chief Financial Officer in an SEC filing |
| Jan 4, 2023 | Carter Houghton reported in an SEC filing no longer being President, Electrochem |
| Oct 6, 2022 | The company announced the departure of Joel Becker as President, CRM & Neuro in an SEC filing |
| May 19, 2022 | Bill R Sanford reported in an SEC filing no longer being a director |
| Apr 4, 2022 | Jennifer M Bolt listed as EVP, Global Operations & ESG (previously SVP, Global Operations & ESG) in SEC filings |
| Mar 11, 2022 | Andrew Senn became SVP, Strategy and Business Dev |
| Jan 21, 2022 | McAlister C Marshall II became SVP, Gen Counsel & Secretary |
| Jan 4, 2022 | Joseph F Flanagan reported in an SEC filing no longer being EVP, Quality & Regulatory Affa |
| Jan 4, 2022 | Jennifer M Bolt listed as SVP, Global Operations & ESG (previously SVP, Global Operations) in SEC filings |
| Jan 4, 2022 | Anthony W Borowicz reported in an SEC filing no longer being SVP Strategy,Corp Dev., IR |
| Jan 3, 2022 | Margaret Carthy became SVP, Quality & Regulatory Affa |
| Feb 1, 2021 | Sheila Antrum became a director |
| Feb 1, 2021 | Cheryl C Capps became a director |
| Feb 1, 2021 | Alvin Tyrone Jeffers became a director |
| May 22, 2020 | Peter H Soderberg reported in an SEC filing no longer being a director |
| Jan 7, 2020 | Jennifer M Bolt listed as SVP, Global Operations (previously President, Electrochem) in SEC filings |
| Aug 15, 2019 | Elizabeth Giddens became SVP, General Counsel |
| May 13, 2019 | Carter Houghton became President, Electrochem |
| Apr 22, 2019 | Joel Becker became President, CRM & Neuro |
| Feb 28, 2019 | Anthony W Borowicz became SVP Strategy,Corp Dev., IR |
| Jan 2, 2019 | Jeremy Friedman reported in an SEC filing no longer being EVP, COO, Interim CFO |
| Oct 2, 2018 | Jason K Garland became EVP, Chief Financial Officer |
| Aug 8, 2018 | Jeremy Friedman listed as EVP, COO, Interim CFO (previously EVP, COO) in SEC filings |
| Feb 20, 2018 | Payman Khales became President, C&V |
| Feb 12, 2018 | James F. Hinrichs became a director |
| Feb 5, 2018 | Tommy P Thomas became VP, Corporate Controller |
| Jan 2, 2018 | Kirk K Thor became Chief Human Resources Officer |
| Jul 19, 2017 | Joseph W Dziedzic listed as President & CEO (previously Interim President & CEO) in SEC filings |
| May 25, 2017 | John A Harris listed as Interim President, C&V (previously VP, Operations Cardio & Vascul) in SEC filings |
| May 23, 2017 | Michael L Spencer became Chief Ethics & Compliance Of |
| May 23, 2017 | Joseph F Flanagan became EVP, Quality & Regulatory Affa |
| May 1, 2017 | Gary J Haire became EVP & Chief Financial Officer |
| Mar 29, 2017 | Joseph W Dziedzic first listed as Interim President & CEO in an SEC filing |
Not reported recently (11)
- Sanjiv Arora · Last reported as SVP, Investor Relations in an SEC filing dated Apr 9, 2025
- Margaret Carthy · Last reported as EVP, Qlty & Regulatory Affairs in an SEC filing dated Feb 25, 2025
- Elizabeth Giddens · Last reported as SVP, General Counsel in an SEC filing dated Aug 17, 2021
- Jose Antonio Gonzalez · Last reported as President, CRM & Neuro in an SEC filing dated Mar 4, 2019
- Michael L Spencer · Last reported as Chief Ethics & Compliance Of in an SEC filing dated Mar 4, 2019
- Timothy G McEvoy · Last reported as Sr. VP, Gen. Counsel & Sec. in an SEC filing dated Jan 2, 2019
- Declan Smyth · Last reported as Pres., Advanced Surgical, Orth in an SEC filing dated May 17, 2018
- Gary J Haire · Last reported as EVP & Chief Financial Officer in an SEC filing dated May 17, 2018
- Thomas J Mazza · Last reported as VP, Corporate Controller in an SEC filing dated Jan 5, 2018
- Thomas J Hook · Last reported as a director in an SEC filing dated Mar 14, 2017
- Kristin Trecker · Last reported as Chief Human Resource Officer in an SEC filing dated Feb 8, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ITGR Proposed Insider Sales (Form 144)
Latest: 2026-09-15
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
3 filings
· $5.8M notice value
· 2 unique filers
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Thor Kirk K (2, $4.6M) · Senn Andrew (1, $1.2M)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | Thor Kirk K | Officer | 4,700 | $593.6K | 2026-09-15 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-09-11 | Thor Kirk K | Officer | 31,540 | $3.98M | 2026-09-11 | Charles Schwab Corp | — | EDGAR |
| 2026-09-08 | Senn Andrew | Officer | 9,408 | $1.19M | 2026-09-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-06-05 | MAXWELL MARTIN C | Director | 8,720 | $1.05M | 2025-06-05 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-06-04 | Spence Donald J | Director | 14,739 | $1.77M | 2025-06-04 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-06-03 | Marshall McAlister C II | Former Officer | 6,830 | $819.6K | 2025-06-03 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-05-01 | Dziedzic Joseph W | Officer, Director | 71,384 | $8.98M | 2025-05-01 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-05-01 | Joseph Dziedzic | Officer | 267,591 | $33.80M | 2025-05-01 | Goldman Sachs & Co. LLC | — | EDGAR |
| 2024-07-31 | MAXWELL MARTIN C | Director | 4,700 | $560.0K | 2024-07-31 | Kestra | — | EDGAR |
| 2024-07-31 | Hobby Jean M. | Director | 11,960 | $1.43M | 2024-07-31 | Fidelity Brokerage Services LLC | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-10-29
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-10-29 | Earnings results | EDGAR |
| 2026-10-21 | Shareholder vote results · Regulation FD disclosure | EDGAR |
| 2026-10-14 | Other events | EDGAR |
| 2026-10-02 | Other events | EDGAR |
| 2026-09-30 | Other events | EDGAR |
| 2026-08-04 | Material agreement · Bylaws or fiscal year change | EDGAR |
| 2026-08-03 | Earnings results | EDGAR |
| 2026-08-03 | Regulation FD disclosure | EDGAR |
| 2026-06-26 | Director or officer change | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
88 ETFs hold ITGR
25 shown · $1.01B total exposure · 0.17% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJR iShares Core S&P Small-Cap ETF | iShares (BlackRock) | 0.25% | $260.3M | $103.8B | 2026-11-06 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $136.4M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.15% | $112.8M | $76.6B | 2026-11-06 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.05% | $96.7M | — | 2026-09-30 |
| 5 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.10% | $62.9M | — | 2026-09-30 |
| 6 | VXF Vanguard Extended Market ETF | Vanguard | 0.05% | $48.3M | — | 2026-09-30 |
| 7 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.30% | $41.1M | $13.9B | 2026-11-06 |
| 8 | SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF | SPDR (State Street) | 0.25% | $39.7M | $15.7B | 2026-11-05 |
| 9 | IJS iShares S&P Small-Cap 600 Value ETF | iShares (BlackRock) | 0.47% | $35.8M | $7.5B | 2026-11-06 |
| 10 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.14% | $25.2M | — | 2026-09-30 |
| 11 | SLYV State Street® SPDR® S&P 600™ Small Cap Value ETF | SPDR (State Street) | 0.47% | $23.3M | $4.9B | 2026-11-05 |
| 12 | IHI iShares U.S. Medical Devices ETF | iShares (BlackRock) | 0.54% | $21.5M | $4.0B | 2026-11-06 |
| 13 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.09% | $20.2M | — | 2026-08-31 |
| 14 | VIOO Vanguard S&P Small-Cap 600 ETF | Vanguard | 0.25% | $15.2M | — | 2026-09-30 |
| 15 | VHT Vanguard Health Care ETF | Vanguard | 0.06% | $13.1M | — | 2026-09-30 |
| 16 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.14% | $12.8M | — | 2026-08-31 |
| 17 | VIOV Vanguard S&P Small-Cap 600 Value ETF | Vanguard | 0.48% | $8.8M | — | 2026-09-30 |
| 18 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.26% | $7.1M | — | 2026-07-31 |
| 19 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.01% | $5.7M | $93.2B | 2026-11-06 |
| 20 | PSC Principal U.S. Small-Cap ETF | Nport | 0.22% | $5.2M | — | 2026-06-30 |
| 21 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.16% | $5.1M | $3.2B | 2026-11-05 |
| 22 | PSCH Invesco S&P SmallCap Health Care ETF | Invesco | 2.35% | $4.2M | — | 2026-11-05 |
| 23 | NUSC Nuveen ESG Small-Cap ETF | Nport | 0.31% | $4.0M | — | 2026-07-31 |
| 24 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.29% | $4.0M | — | 2026-09-30 |
| 25 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $4.0M | — | 2026-11-05 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
43.49
TTM Diluted EPS
$2.91
TTM Revenue
$1.83B
TTM Net Income
$103.70M
TTM Op. Cash Flow
$176.48M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-10-02 | $449.66M | $14.98M | $0.43 | $36.63M |
| Q2 '26 | 2026-07-03 | $464.11M | $23.61M | $0.69 | $59.73M |
| Q1 '26 | 2026-04-03 | $439.58M | $16.51M | $0.48 | $24.70M |
| Q4 '25 | 2025-12-31 | $472.06M | $48.61M | $1.37 | $55.41M |
| Q3 '25 | 2025-09-26 | $467.69M | $39.68M | $1.11 | $65.59M |
| Q2 '25 | 2025-06-27 | $476.49M | $37.01M | $1.04 | $43.86M |
| Q1 '25 | 2025-03-28 | $437.39M | $-22.46M | $-0.66 | $31.28M |
| Q4 '24 | 2024-12-31 | $449.50M | $32.70M | $0.90 | $63.23M |
| Q3 '24 | 2024-09-27 | $431.42M | $35.44M | $0.99 | $71.50M |
| Q2 '24 | 2024-06-28 | $427.89M | $31.25M | $0.88 | $47.23M |
| Q1 '24 | 2024-03-29 | $407.80M | $20.51M | $0.59 | $23.24M |
| Q4 '23 | 2023-12-31 | $404.50M | $26.36M | $0.78 | $56.32M |
Q3 2026 • period ending 2026-10-02 • filed 2026-10-29
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
43.49
P/B
2.57
P/S
2.40
EV/EBITDA
16.79
EV/Sales
3.09
ROE
7.5%
ROA
3.8%
Div Yield
0.00%
FCF Yield
4.65%
Debt/Equity
0.75
Current Ratio
—
Market Cap
$4.42B
as of 2026-11-09
ITGR vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| ABT Abbott Laboratories | $190.4B | 40.9 | +10.0% | −11.0% | 20 |
| ISRG Intuitive Surgical Inc. | $160.0B | 55.7 | +20.5% | −18.0% | 12 |
| MDT Medtronic plc | $130.2B | 25.3 | +9.8% | +7.0% | 69 |
| PTGX Protagonist Therapeutics, Inc | $8.5B | 133.2 | +34.8% | +55.9% | 3 |
| LNTH Lantheus Holdings, Inc | $6.6B | 24.5 | +2.3% | +50.2% | 4 |
| TFX Teleflex Incorporated | $6.4B | — | −17.7% | +26.4% | 2 |
| ITGR Integer Holdings Corporation | $4.3B | 43.5 | −0.3% | +64.8% | 9 |
| OGN Organon & Co. | $3.6B | 18.0 | −3.2% | +91.3% | 20 |
| PCRX Pacira BioSciences, Inc. Common Stock | $1.5B | 104.2 | +5.7% | +49.1% | 1 |
| Peer median | $7.6B | 40.9 | +7.8% | +37.7% | 8 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
3.25M
SI % of Float
9.64%
Days to Cover
3.70
Short Vol Ratio
23.5%
Free Float
33.72M
Float %
99.2%
Short interest 2026-10-15 • Short volume 2026-11-09 • Float 2026-09-22